Combination Therapy with Inolimomab and Etanercept for Severe Steroid-Refractory Acute Graft-versus-Host Disease-Reference-Cited by-同舟云学术

Combination Therapy with Inolimomab and Etanercept for Severe Steroid-Refractory Acute Graft-versus-Host Disease

Published:2016-01 Issue:1 Volume:22 Page:179-182
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

van Groningen Lenneke F.J.,Liefferink Aleida M.,de Haan Anton F.J.,Schaap Nicolaas P.M.,Donnelly J. Peter,Blijlevens Nicole M.A.,van der Velden Walter J.F.M.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference21 articles.

1. Graft-versus-host disease;Ferrara;Lancet,2009

2. How I treat refractory acute GVHD;Deeg;Blood,2007

3. First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation;Martin;Biol Blood Marrow Transplant,2012

4. Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease;Ferrara;Blood,2011

5. Glucocorticoid-refractory acute graft-versus-host disease;Pidala;Biol Blood Marrow Transplant,2010

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ruxolitinib Plus Basiliximab Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease in Unrelated Cord Blood Transplantation: A Large-Scale Study;Transplantation and Cellular Therapy;2024-09

2. Ruxolitinib for the treatment of acute graft-versus-host disease: a retrospective analysis;Annals of Hematology;2024-06-25

3. Ruxolitinib plus basiliximab therapy for steroid-refractory acute graft-versus-host disease in unrelated cord blood transplantation: a large-scale study;2024-03-21

4. Basiliximab Treatment for Patients With Steroid-Refractory Acute Graft-Versus-Host Disease Following Matched Sibling Donor Hematopoietic Stem Cell Transplantation;Cell Transplantation;2024-01

5. Second-line therapy for patients with steroid-refractory aGVHD: systematic review and meta-analysis of randomized controlled trials;Frontiers in Immunology;2023-06-20